Pfizer Inc.

Pfizer Inc.


For over 160 years, we’ve been innovating to make the world a healthier place. Visit https://t.co/YjZgM1r3ic to learn more. https://t.co/K5kUC0xMQ2

402618 followers  •  2367 follow  •    •   https://t.co/YGqLZyvAi4

Cases of #kidneycancer  are increasing among all racial groups in the US, with the largest increase seen in Black Americans. We’re working with this community to provide resources and support to people living with kidney cancer. #KCAM 

The @NatGeo  documentary "Mission Possible-The Race for a Vaccine" premiered last week--uncovering the history-making endeavor to develop the first #COVID19  vaccine. #ICYMI , you can watch the full documentary via Youtube here: . #PfizerProud 

tweet picture

Scientists are developing an innovative treatment approach that can both make it past bouncers guarding the entrance to the brain and defeat tumors inside.

Today, we announced that we’ve started testing the safety profile of our novel oral #antiviral  investigational drug candidate for SARS-CoV-2 infections. #COVID19  #ScienceWillWin 

Today, with @BioNTech_Group , we announced positive topline results in adolescents 12-15 years of age from the Phase 3 Pfizer-BioNTech#COVID19  vaccine study.

Topline data from 2,260 adolescents demonstrated high antibody responses and 100% efficacy against #COVID19  , and that the vaccine was well-tolerated.

BREAKING: Today, with @BioNTech_Group , we submitted a request to US FDA to expand emergency use of our COVID-19 vaccine to adolescents 12 to 15 years of age.

tweet picture

Pending regulatory decision, our hope is to make this vaccine available to the 12-15-year-old age group before the start of the 2021 school year.

The next big thing in the fight against the pandemic could be antivirals. These medicines reduce viral symptoms and prevent viruses from spreading in the body. Learn more about our #antiviral  candidate for #COVID19 .

Loading
Loading

UPDATE: We are proud to announce, along with @BioNTech_Group , that our mRNA-based #vaccine  candidate has, at an interim analysis, demonstrated initial evidence of efficacy against #COVID19  in participants without prior evidence of SARS-CoV-2 infection.

BREAKING: We are proud to announce, along with @BioNTech_Group , that the Phase 3 study of our #COVID19  vaccine candidate has met all primary efficacy endpoints.

An update from @AlbertBourla  on our investigational #COVID19  vaccine program with @BioNTech_Group .

#COVID19 UPDATE: We will submit a request today to the @US_FDA  for Emergency Use Authorization (EUA) of our mRNA vaccine candidate with @BioNTech_Group .

It has before. It will again. Why we believe, that SCIENCE will win. RT if you agree. #ScienceWillWin  #InItTogether 

📸: The first shipment from our Kalamazoo plant. @UPS  @FedEx  . . The Pfizer-BioNTech #COVID19  vaccine has not been approved or licensed by the @US_FDA  but has been authorized for emergency use to prevent COVID-19 in individuals 16+. See conditions of use:

Imagine a world without #science . This #EarthDay , we're proud to stand behind our scientists & the #ScienceMarch . ????????

Loading
Loading